PREPOPIK
- Product NDC
- 55566-9700
- 11-digit product format
- 555669700
- Labeler code
- 55566
- Product ID
- 55566-9700_ad05efef-dafe-496f-a008-8d30abd53138
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
- Dosage form
- POWDER, METERED
- Route
- ORAL
- Labeler
- Ferring Pharmaceuticals Inc.
- Application
- NDA202535
- Marketing category
- NDA
- Marketing start
- 2014-09-05
- Marketing end
- 2020-05-31
- Substance
- SODIUM PICOSULFATE; MAGNESIUM OXIDE; ANHYDROUS CITRIC ACID
- Active strength
- 10 mg/16.2g; g/16.2g; g/16.2g
- Pharmacologic classes
- Increased Large Intestinal Motility [PE],Stimulant Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record